Compare Alcon AG (ALC) vs Procter & Gamble Co (PG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Procter & Gamble Co — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Procter & Gamble Co trades at $148.56 (market cap $355.69B). The key difference: Procter & Gamble Co is far larger — about 10.9× Alcon AG's market cap, and Procter & Gamble Co pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| ALC | PG | |
|---|---|---|
Market Cap | $32.69B | $355.69B |
Sector | Health | Consumer Staples |
52-Week High | $92.22 | $167.18 |
52-Week Low | $62.02 | $138.10 |
Enterprise Value | $36.28B | $381.17B |
Dividend Yield | 0.54% | 2.79% |
Volume | — | 6,423,436 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Procter & Gamble (PG) trades at $148.40, down 0.61% on the day, with strong technical momentum showing bullish moving averages and key support at $148. The company demonstrates stable fundamentals with $84.28B revenue in 2025, 19.16% net margin, and consistent earnings beats in recent quarters. Recent corporate developments include a $1.09 dividend payment and new WNBA partnership, while analyst consensus remains positive with 55.77% buy ratings.
PG presents a stable investment case with reliable dividend income and defensive positioning, though premium valuation multiples create near-term execution pressure. The stock offers moderate upside to consensus target of $159.88 but faces risks from consumer demand softness and competitive pressures in the consumer staples sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
